TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Chiron Pharmasynth AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
14,710
|
9,316
|
9,313 |
Financial expenses |
124
|
134
|
130 |
Earnings before taxes |
1,893
|
3,845
|
4,946 |
Total assets |
28,458
|
25,541
|
21,661 |
Current assets |
28,458
|
25,541
|
21,647 |
Current liabilities |
10,880
|
9,769
|
7,222 |
Equity capital |
17,578
|
15,772
|
14,439 |
- share capital |
1,775
![]() |
1,775
![]() |
1,775 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
61.8%
![]() |
61.8%
|
66.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
12.9%
|
41.3%
|
53.1% |
Return on assets (ROA) |
7.1%
|
15.6%
|
23.4% |
Current ratio |
261.6%
|
261.4%
|
299.7% |
Return on equity (ROE) |
10.8%
|
24.4%
|
34.3% |
Change turnover |
5,394
|
3
|
-1,665 |
Change turnover % |
58%
|
0%
|
-15% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.